{"database":"GEO","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE331nnn/GSE331364/"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Transcriptomics"],"species":["Mus musculus"],"gds_type":["Expression profiling by high throughput sequencing"],"full_dataset_link":["https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE331364"],"repository":["GEO"],"entry_type":["GSE"],"additional_accession":[]},"is_claimable":false,"name":"Fatty acid ethanolamides-producing gut bacteria alleviate gastrointestinal symptoms in diarrhea-predominant irritable bowel syndrome with coexisting insulin resistance","description":"We used fresh ileum tissue samples and performed single-cell RNA sequencing with the DNBelab C4 platform to investigate the mechanisms by which OEA treatment affects IBS-D-related symptoms in TNBS-treated mice. This approach enabled us to analyze cell-type-specific transcriptomic changes and to identify key cellular responses following OEA intervention in the context of TNBS-induced IBS-D symptoms","dates":{"publication":"2026/06/15"},"accession":"GSE331364","cross_references":{"GSM":["GSM9744689","GSM9744691","GSM9744690","GSM9744684","GSM9744683","GSM9744682","GSM9744681","GSM9744688","GSM9744687","GSM9744686","GSM9744685"],"GPL":["28330"],"GSE":["331364"],"taxon":["Mus musculus"]}}